Data stemming from clinical trials conducted outside the Union may be taken into consideration for the assessment of an application for a marketing authorisation only if those trials were designed, implemented and reported in accordance with the international guidelines on good clinical practice of the VICH.
Ní fhéadfar sonraí a thagann ó thrialacha cliniciúla arna ndéanamh lasmuigh den Aontas a chur san áireamh chun measúnú a dhéanamh ar iarratas ar údarú margaíochta ach amháin i gcás ina ndearnadh na trialacha sin a dhearadh, a chur chun feidhme agus a thuairisciú i gcomhréir le treoirlínte idirnáisiúnta VICH maidir le dea-chleachtas cliniciúil.